The Alliance for Connected Care sent the attached letter to the White House Office of National Drug Control Policy (ONDCP) applauding their inclusion of the telemedicine special registration for the prescribing of controlled substances this year as part of the Biden Administration’s First-Year Drug Policy Priorities.
The Biden Administration outlined its drug policy priorities for its first year, stressing harm reduction, racial equity and helping people with substance use disorder find employment. As part of the announcement there was included a commitment to move forward the special registration for telemedicine prescribing of controlled substances this year. As you remember, the Alliance led a letter on this issue last fall (in addition to many previous actions).
“In the first year, the Biden-Harris Administration will work through ONDCP to coordinate with other White House components and the interagency to:
- Publish final rules this year regarding telemedicine special registration and methadone treatment vans; and”
Read the full letter here and below: